Natural history of ALS: symptoms, strength, pulmonary function, and disability.
about
Segmentation of the human spinal cordComprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.A novel fixed-target task to determine articulatory speed constraints in persons with amyotrophic lateral sclerosisOptimizing care of patients with ALS. Steps to early detection and improved quality of life.Management of motor neurone diseaseOutcome of ventilatory support for acute respiratory failure in motor neurone disease.Advanced statistical methods to study the effects of gastric tube and non-invasive ventilation on functional decline and survival in amyotrophic lateral sclerosisDesign and characterization of a synthetically accessible, photodegradable hydrogel for user-directed formation of neural networksBiologically inspired approaches to drug delivery for nerve regeneration.KNS-760704 [(6R)-4,5,6,7-tetrahydro-N6-propyl-2, 6-benzothiazole-diamine dihydrochloride monohydrate] for the treatment of amyotrophic lateral sclerosis.A timeline for predicting durable medical equipment needs and interventions for amyotrophic lateral sclerosis patients.Motor neuron disease: current management and future prospects.Patterns of clinical and electrodiagnostic abnormalities in early amyotrophic lateral sclerosis.Accrued somatic mutations (nucleic acid changes) trigger ALS: 2005-2015 update.Outcome measures in amyotrophic lateral sclerosis clinical trialsHomeostatic dysregulation in membrane properties of masticatory motoneurons compared with oculomotor neurons in a mouse model for amyotrophic lateral sclerosis.Outcome of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis in relation to respiratory dysfunction.An association study of riluzole serum concentration and survival and disease progression in patients with ALS.Ability of pulmonary function decline to predict death in amyotrophic lateral sclerosis patients.The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening.Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis.Does apolipoprotein E genotype modify the clinical expression of ALS?Mortality risk associated with disability: a population-based record linkage study7-T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosis
P2860
Q27007796-DC82758A-5FC1-4991-8B89-5AF6585EEC29Q30365902-710F38CB-66CB-48EC-8351-64C08A7D58DFQ30459549-EFEF3D3F-C2EE-497F-8E04-59A8322FA0CFQ33605267-CE56146A-83A7-4065-9445-E2C44118C3B7Q34530167-FA6F06D7-770B-4051-B66D-138782368FEEQ34649259-C9C5F83E-9582-4539-9F4F-2A11E294C21DQ35110299-0B764EB6-031F-482F-A7F2-0BF6EF56A637Q36118313-34850E4F-9A95-4104-BB45-BDD44EADA79BQ36627231-7E86C101-E3C9-4C70-8ECC-6FA2B1893590Q37272764-DAB09089-7173-4E54-89C9-B4FD1B0598FCQ37468693-7522D367-2441-4D21-8D33-63F0EA395B0BQ38597450-7D9C9C22-2B63-4D9F-9107-F845896106FDQ39227306-BE58E4D5-94D3-4D95-99FE-93027CBB3CA8Q40957607-22A03118-E2E3-4C23-AEDB-F33BDBAF219BQ41837997-31668CF9-9D2F-4945-B027-A9B2A641D604Q43104922-ABDBCC9E-1B24-4DBD-9DC4-045E2C5C9FCCQ45834358-89388177-F767-48DF-8BB5-4E5FE155DD4BQ46979428-036EA1AD-4660-4CC3-8D4F-FC8D9DDC1B94Q47316807-7D645611-4608-4185-B635-5B0D473134D2Q47875785-A16D217C-683D-4598-9DE4-BBF806E5B9C2Q53556253-DC2AFC83-3A2B-43DD-9F96-2084630A5C79Q54408959-24C04FE1-142F-4D22-8D2A-6029A1AD951CQ57418002-9183EAC9-604D-4533-A6AA-17F368437F69Q57592495-73B782F7-1963-477F-B85B-4C17DCB22210
P2860
Natural history of ALS: symptoms, strength, pulmonary function, and disability.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Natural history of ALS: symptoms, strength, pulmonary function, and disability.
@en
type
label
Natural history of ALS: symptoms, strength, pulmonary function, and disability.
@en
prefLabel
Natural history of ALS: symptoms, strength, pulmonary function, and disability.
@en
P1433
P1476
Natural history of ALS: symptoms, strength, pulmonary function, and disability.
@en
P2093
P304
S71-81; discussion S81-2
P356
10.1212/WNL.47.4_SUPPL_2.71S
P407
P433
P577
1996-10-01T00:00:00Z